NIH-funded research Career grant

The role of gut bacteria in pancreatic cancer development and progression

Official title: Microbial Dysbiosis in Pancreatic Cancer Initiation and Progression

Funded at University of Michigan at Ann Arbor · NIH-10893577 · Data updated 2026-11-12

This study is looking at how changes in gut bacteria might affect the development and growth of pancreatic cancer, and it’s inviting patients to help by sharing samples or information to better understand how these bacteria interact with tumors and could lead to better treatments.

More Pancreatic Cancer research and trials

Quick facts

Grant typeCareer grant
Study typeNIH-funded research
Funding institutionUniversity of Michigan at Ann Arbor
NIH-funded
Lab location1 site (Ann Arbor, United States)
Project startAugust 1, 2023
Project endJuly 31, 2028
Funding year2024
Award (this year)$280,670
NIH project number5K08CA282374-02
Project IDNIH-10893577 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with pancreatic cancer or those at high risk for developing the disease.

Less likely to help

Patients with non-cancerous conditions or those not diagnosed with pancreatic cancer may not benefit from this research.

What this research studies

This research investigates how changes in gut bacteria, known as microbial dysbiosis, may influence the initiation and progression of pancreatic cancer. By examining the unique microbiome present in pancreatic tumors, the study aims to uncover the mechanisms through which these bacteria affect immune responses and tumor growth. The researchers will explore how pathogenic bacteria interact with pancreatic cells and alter the tumor microenvironment, potentially leading to more effective treatments. Patients may be involved in providing samples or data to help understand these interactions better.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic strategies that improve survival rates for pancreatic cancer patients.

How similar studies have gone: Other research has shown promising results in understanding the role of microbiomes in various cancers, suggesting that this approach could yield valuable insights.

Where this research is happening

  • University of Michigan at Ann Arbor
    Ann Arbor, United States
    Active

Researchers

  • Principal investigator: Daley, Donnele — University of Michigan at Ann Arbor
  • Study coordinator: Daley, Donnele

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.